{"id":"W2118093436","doi":"10.3109/15412555.2013.791809","title":"One-Year Extension Study of ACCORD COPD I: Safety and Efficacy of Two Doses of Twice-daily Aclidinium Bromide in Patients with COPD","year":2013,"lang":"en","type":"article","venue":"COPD Journal of Chronic Obstructive Pulmonary Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Tolerability; Anticholinergic; Placebo; Adverse effect; Discontinuation; Incidence (geometry); Internal medicine; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00290273,0.001577624,0.002790381,0.0004522505,0.0005553521,0.0007586476,0.0006979071,0.001353222,0.002013514],"category_scores_gemma":[0.001706873,0.0006524063,0.001453848,0.0003016177,0.0006930597,0.0007693029,0.0005593293,0.002437428,0.0005538025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004548886,"about_ca_system_score_gemma":0.001086994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007240135,"about_ca_topic_score_gemma":0.001574153,"domain_scores_codex":[0.9990934,0.0005129047,0.00005918291,0.0001154861,0.00007898716,0.0001401058],"domain_scores_gemma":[0.9976656,0.000379806,0.0004776953,0.0002939621,0.0001822121,0.001000615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9285662,0.03908721,0.00612284,0.0002625261,0.000562384,0.00007955288,0.0001153916,0.0002435937,0.008858057,0.00004615562,0.0004497864,0.01560617],"study_design_scores_gemma":[0.530031,0.4462231,0.02151645,0.00001816249,0.0004188076,0.00006101467,0.00003222778,0.0002534227,0.0008110733,0.00004041791,0.0005706469,0.00002370365],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966329,0.0008048323,0.0002209179,0.0001040656,0.00008150617,0.001119733,0.0003579035,0.00004588107,0.0006322992],"genre_scores_gemma":[0.9935772,0.0005962656,0.0008418233,0.0005572037,0.0002914562,0.001666993,0.0009946673,0.00001091415,0.001463507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00290273,"threshold_uncertainty_score":0.0153513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01414249304186827,"score_gpt":0.2763778869723459,"score_spread":0.2622353939304777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}